Penumbra, Inc.

US$319.21As of Sun 8 Nov 2026, 12:00 UTC
NYSE:PENHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 17.04%
Div yield —
ROE 10.67%
Medical Devices
Beta (5Y) 0.69
PE TTM 80.43
TSR TTM 40.39%
Mkt cap US$12.58B
ROIC 12.97%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$371
16.15%
(54.01%)
Hold 11|5|1|5|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
4.45
4.97
5.12
4.87
12.79%
15.15%
21.81%
8.00%
Revenue$M
739.5
781.9
769.9
810.0
0.51%
8.34%
7.66%
14.41%
Peers (US$12.58B)
Cap (US$)
PE
10.16B
23.90x
13.08B
20.86x
Capital
TTM
5Y
10Y
Leveragex
3.525
(0.779)
(0.523)
EBIT/Intx
1.076
0.174
0.225
Own earn%
28.42
101.68
94.24
Sh yield%
52.83
48.72
49.90
Owners
Insiders/Inst%
1.75
33.15
Short interest%
5.95
SBC / revenue%
5.19
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
14–21
$1 testx
0.0
Incr. ROIC%
−1